While the application of normative standards is vital to the practice of clinical neuropsychology, data regarding normative change remains scarce despite the frequency of serial assessments. Based on 285 normal individuals, we provide co-normed baseline data with demographic adjustments and test-retest standardized regression based (SRB) models for three time points for several measures. These models delineate normal, expected change across time, and yield standardized z-scores that are comparable across tests. Using a new approach, performance on any previous trial was accounted for in the subsequent models of change, yielding serial normative formulas that model change trajectories rather than simple change from point to point. These equations provide indices of deviation from expected baseline and change for use in clinical or research settings.
INTRODUCTION
Because norm-referenced scores provide the basis of interpretative statements concerning a patient's functional status, diagnosis, and treatment needs, recent texts stress not only the importance of informed test selection but also the importance of selecting norms that are appropriate for the goals of the assessment (Lezak, Howieson, & Loring, 2004; Mitrushina, Boone, Razani, & D'Elia, 2005; Strauss, Sherman, & Spreen, 2006) . Analysis of change is central to addressing diagnostic questions, and it is based on a discrepancy model in which an observed performance is noted to deviate from an expected level (Hawkins & Tulsky, 2003) . Heaton and colleagues (Heaton, Taylor, & Manly, 2003) observe that there is overwhelming evidence that demographic factors such as age, education, gender, and ethnicity significantly affect an individual's observed cognitive performance. By adjusting normative data for relevant demographic factors, an individual comparison standard is generated against which a specific patient's observed scores can be compared (Mitrushina et al., 2005; Strauss et al., 2006) . While population-based norms describe where a patient's performance falls relative to the mean of the general population, demographically adjusted norms inform the clinician how far a patient's observed performance deviates from his or her expected performance (Busch, Chelune, & Suchy, 2006) . The diagnostic value of these deviations can be evaluated using base-rate data, test-operating characteristics such as sensitivity and specificity, receiver-operating characteristics, and estimates of relative risk (Ivnik et al., 2000 (Ivnik et al., , 2001 , and lend themselves to evidence-based research and practice (APA Presidential Task Force on Evidence-Based Practice, 2006; Chelune, 2002) .
Demographically adjusted norms have been developed for many individual test measures such as the California Verbal Learning Test (Delis, Kramer, Kaplan, & Ober, 2000) , Hopkins Verbal Learning Test (Vanderploeg et al., 2000) , MicroCog (Powell, Kaplan, Whitla, Catlin, & Funkenstein, 1993) , Mattis Dementia Rating Scale (Lucas et al., 1998; Schmidt et al., 1994) , Ruff Figural Fluency Test (Ruff, 1996) , and Wisconsin Card Sorting Test (Heaton, Chelune, Talley, Kay, & Curtiss, 1993) . While such norms provide useful individual comparison standards for evaluating the diagnostic value of the specific test, caution must be exercised when using such tests within the context of a battery since the tests were standardized on different populations at different points in time, and the intercorrelations between measures and the base rate of discrepancies scores are often not known. To overcome these limitations, there is a growing appreciation of the value of test batteries that have been co-normed using the same population with known demographic features. Examples of such demographically adjusted norms include those for the expanded Halstead-Reitan Battery (Heaton, Miller, Taylor, & Grant, 2004) , the Mayo Older Americans Normative Studies (Ivnik, Malec, Smith, Tangalos, & Petersen, 1996; Ivnik et al., 1990 Ivnik et al., , 1992a Ivnik et al., , 1992b Ivnik et al., , 1997 Ivnik, Tangalos, Petersen, Kokmen, & Kurland, 1992c; Lucas et al., 1998; Malec et al., 1992) , the third editions of the Wechsler Intelligence and Memory Scales (Taylor & Heaton, 2001; The Psychological Corporation, 2002; Wechsler, 1997) , the Neuropsychological Assessment Battery (NAB; Stern & White, 2001) , and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS; Randolph, 1998) . The NAB and RBANS are notable because they are among the few test batteries that are intended for both single-point assessments as well as repeated use, albeit using alternative forms.
While neuropsychological tests are generally designed to assess the current state or capacity of the individual, there are an increasing number of situations in which patients require serial testing to monitor change in cognitive status as a function of disease progression, treatment response, surgical or pharmacological intervention, and recovery of function (Busch et al., 2006; Chelune, 2003; Chelune, Naugle, Luders, Sedlak, & Awad, 1993; Collie, Maruff, Darby, & McStephen, 2003; Lineweaver & Chelune, 2003; Strauss et al., 2006) . In these situations, the patient's observed baseline performance becomes the individual comparison standard against which test-retest change is evaluated, and the variable of interest is the test-retest discrepancy or change score. Interpretation of the clinical significance of these change scores is complicated by practice effects, measurement error, and regression to the mean (Bruggemans, Van de Vijver, & Huysmans, 1997; Chelune, 2003; Lineweaver & Chelune, 2003) . Interpretation of change scores at the level of the individual is further complicated by patient characteristics such as age, education, and baseline ability, which can influence rate of change although not necessarily uniformly across individuals. While use of alternate forms has been suggested as a useful approach to minimize practice effects (Benedict & Zgaljardic, 1998; Delis et al., 2000; Randolph, 1998; Stern & White, 2001) , research still demonstrates significant practice gains (Beglinger et al., 2005; Hinton-Bayre & Geffen, 2005) , as alternative forms do not control for procedural or skill-based learning or other factors that contribute to the overall practice effect (Busch et al., 2006) . Because alternate forms do not fully remedy practice effects nor meet the psychometric challenges posed by bias and error inherent in serial assessments, methods of assessing reliable change have been developed.
Reliable change methods are essentially a family of statistical procedures that attempt to take into account with varying degrees of success practice effects, measurement error, and regression to the mean by describing the spread or distribution of test-retest change scores that would be expected to occur in the absence of true change (Basso, Bornstein, & Lang, 1999; Chelune et al., 1993; Dikman, Heaton, Grant, & Timken, 1999; Hermann et al., 1996; Iverson, 2001; Jacobson & Truax, 1991; McSweeny, Naugle, Chelune, & Luders, 1993; Sawrie, Chelune, Naugle, & Luders, 1996) . Meaningful change is typically determined when an observed difference score exceeds a specified confidence interval set around the mean of the expected change score. These procedures are increasingly being used in outcomes research such as epilepsy surgery Hermann et al., 1996 Hermann et al., , 1999 Martin et al., 2002; Sawrie et al., 1996; Seidenberg et al., 1998) , cardiac procedures (Andrew, Baker, Bennetts, Kneebone, & Knight, 2001; Bruggemans, van de Vijver, & Huysmans, 1999; Collie, Darby, Falleti, Silbert, & Maruff, 2002; Kneebone, Andrew, Baker, & Knight, 1998; Lehrner et al., 2005 ; M. S. Lewis, Maruff, Silbert, Evered, & Scott, 2006) , traumatic brain injury (Dikman et al., 1999; Ferland, Ramsay, Engeland, & O'Hara, 1998; McCrea et al., 2005; Temkin, Heaton, Grant, & Dikmen, 1999) , post-operative cognitive dysfunction (Farag, Chelune, Schubert, & Mascha, 2006; M. Lewis, Maruff, & Silbert, 2004; Maze & Todd, 2007; Murkin, 2001) , and aging Ivnik et al., 1999; Knight, McMahon, Skeaff, & Green, 2007; Raymond, Hinton-Bayre, Radel, Ray, & Marsh, 2006; Sawrie, Marson, Boothe, & Harrell, 1999; Tombaugh, 2005) .
While there is growing interest in the use of longitudinal multivariate mixed models to assess cognitive change (Chu et al., 2007; Salthouse, 2007) , the use of Standardized Regression-Based (SRB) models remains one of the most powerful means for assessing reliable change at the level of the individual (Chelune, 2003) . Introduced by McSweeny and colleagues (1993) , the SRB approach involves regression modeling to derive prediction equations for retest scores based on initial baseline performances. In addition to baseline scores, these regression equations are often multivariate and include demographic variables and other potentially relevant factors that might affect the rate of test-retest change (Chelune, 2003; Hermann et al., 1996; Sawrie et al., 1996) . Norms for expected change can be derived in the form of standardized z-scores by dividing the difference between the observed and regression predicted retest scores by the Standard Error of the Estimate (SEE) for the regression equation. Similar to demographically adjusted norms for single-point evaluations, the SRB equations can be used with individual patients to determine whether the patient's observed rate of change deviates significantly from expectation. SRB norms of expected change also have the advantage of taking into account differences in reliability and susceptibility to practice between test measures such that change scores for groups of variables are expressed on a common metric, facilitating betweenvariable discrepancy analysis (Chelune, 2003) .
The current study is divided into two parts, and presents normative baseline and test-retest change data over three time points for a sample of normal individuals. Part 1 provides co-normed data with subsequent demographic adjustments for 14 variables derived from eight commonly used neuropsychological tests. Part 2 provides SRB norms of expected change across three time points. In addition to providing the SRB prediction equations to forecast expected change from Time-1 (T 1 ) to Time-2 (T 2 ), we also apply a relatively new approach (Chelune, Attix, & Story, 2007; Chelune, Ivnik, & Smith, 2006) for predicting change at Time-3 (T 3 ). Whereas previous authors (e.g., McCrea et al., 2005) have employed the SRB approach to predict retest performance across multiple time points using baseline scores alone, we used both baseline (T 1 ) and initial change (T 2 -T 1 ) to predict subsequent change scores. This method models the potential impact of differential practice effects on subsequent retest performances, yielding prediction equations that reflect neuropsychological trajectories over time.
METHOD Participants
An archival sample of 285 normal participants who took part in an investigation of the potential human health effects of exposure to a naturally occurring dinoflaggellate, Pfiesteria Piscicida, was used. The parent study was an epidemiological surveillance research project funded by the Centers for Disease Control and Prevention utilizing a prospective longitudinal design. North Carolina and Virginia participants were assessed for the detection of Pfiesteria-related health problems associated with occupational or recreational water contact. While there were limited Pfiesteria-associated fish kills during the study period, a series of analyses on variables reflecting various parameters of exposure was conducted. These parent study analyses failed to reveal any consistent, significant association between exposure indicators and neuropsychological test performance (Turf et al., 1999; Moe, 2004) .
Participants were aged 18 to 71 (M ¼ 43.4, SD AE 11.7; 15% aged 18-30; 82.8% aged 31-64; 2.2% 65þ), with an average education of 12.4 years (SD AE 2.5; range 6-20, 23.6% 5 12, 39.3% ¼ 12, 37.4%412) and a mean Wide Range Achievement Test-3 Reading scaled score of 92.7 (SD AE 13.9). They were primarily male (244 males/41 females), and all were Caucasian. Participants had no known neurological conditions, history of treatment for substance abuse, or diagnosis of psychosis/treatment with antipsychotic agents. Also excluded were participants with a history of traumatic brain injury with loss of consciousness longer than 30 minutes or persisting cognitive sequelae sufficient to interfere with daily functioning, a history of solvent or pesticide poisoning, insulin-dependent diabetes, or a history of placement in school classes for developmentally disabled individuals. Finally, those who had participated in other studies involving Pfiesteria or estuary syndromes were excluded.
Study participants were examined at entry and every 5 to 7 months with a medical exam and neuropsychological assessment over a 1.5-year period. The mean test-retest interval was 177 (SD 51) days for Time 2, and 195 (SD 91) days for Time 3. In North Carolina participants also completed biweekly telephone interviews to document perceived symptoms. Some participants completed exams ''triggered'' by exposure to a fishkill or cognitive symptom complaints. In such cases, the subsequent assessment was scheduled for 5-7 months after the triggered exam to maintain an equal exam interval between participants. Performance as a function of routine versus triggered visits did not differ.
The Institutional Review Board of all participating medical centers approved the study (Duke University Medical Center, University of North Carolina-Chapel Hill, Virginia Commonwealth University, and Eastern Virginia Medical School). Participants provided written informed consent, and were compensated $100 for each half-day medical and neuropsychological examination. Only participants with data for all three visits were included in the current analysis for each measure. Table 1 outlines the test instruments used. Standardized administration and scoring procedures were utilized for each neuropsychological measure, with the exception of minor modifications for the Rey-Osterreith Complex Figure Test (ROCFT) and Rey Auditory Verbal Learning Test (RAVLT). Specifically, only copy and delayed recall trials of the ROCFT were given. In order to avoid ceiling effects, administration alternated between two versions of the RAVLT (A-B-A; immediate recall after the interference list was given for all participants, but only a subset of these data was archived and available for analyses from participating sites). The use of regression modeling to control for practice effects and other sources of error was anticipated, and thus alternate forms were only administered when ceiling effects were expected (i.e., RAVLT), and were administered in the same order for all participants, such that covarying test version was unnecessary. Time was also not examined as a performance modifier as the test-retest interval was by study design restricted in range.
Procedures

Data analyses
Analyses proceeded in two parts: Part 1 -baseline co-norming, and Part 2 -normative change over time. In Part 1, stepwise linear regression was used to create formulas that delineate co-normed demographically corrected baseline performance for the sample, using age, education, and sex as predictors. These equations provide indices of deviation from expected baseline performance for use in clinical or research settings. In Part 2 stepwise linear regression and SRB procedures were utilized to predict normative change trajectories over time, with age, education, sex, and previous raw test scores as potential predictors.
RESULTS
Part 1: Baseline co-normed performance
Mean raw scores on the variables of interest for the sample at baseline (T 1 ), Time 2 (T 2 ), and Time 3 (T 3 ) examinations are presented in Table 2 . Significant differences between time points are noted in Table 2 based on one-way repeated measures ANOVAs and post-hoc Tukey tests. Based on these analyses, statistically significant practice effects for each measure were observed over the three time points. The RAVLT was the only measure showing a decline rather than gain at T 2 , likely due to differences in alternate-form difficulty.
Normative performance was estimated using linear regression with all data available for the sample. Age, education, and sex were entered into all models as potential predictors. Normative formulas based on the models are found in Table 3 . These models account for 5-45% of the variance in the sample as noted by the R 2 values in Table 2 .
Application. For use of these formulas in a clinical setting, consider the following case example. A 56-year-old male with 10 years of education obtains a baseline score of 32 on the Stroop Test. This score falls 5.44 points below the sample mean of 37.44 (see Table 2 ), or À0.63 SD (z-scores) below average (z ¼ À5.44/8.7 ¼ À0.63). While we know that this individual falls À0.63 SD below the normative sample's mean or at the 27th percentile, we do not know whether this person's performance actually deviates from other men with similar demographic characteristics. However, if we apply the regression-based formulas in Table 3 we can more accurately delineate his actual divergence from his demographic cohort by considering the relevant modifying demographic variables, which account for close to half of the variance of some measures. The patient's predicted score is first calculated using the regression equation in Table 3 for Stroop, which is then subtracted from the observed score and divided by the standard error of the estimate (SEE).
Deviation from Expected Score ¼ Observed score ð32Þ À Predicted score ð32:49Þ Standard Error of the Estimate ð8:04Þ ¼ z-score of À 0:06 Table 3 Formulas predicting baseline performance 
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In this example we see that the patient's baseline score of 32, while more than half SD below the average of the general normative sample (z ¼ À0.63), actually falls near expectation (z ¼ À0.06) relative to his demographic peers (48th percentile).
Part 2: Trajectories of neuropsychological change
Mean changes on the variables of interest for the sample across time were calculated by subtracting the previous raw score from the relevant subsequent raw score (e.g., T 2 -T 1 for calculation of average change from T 1 !T 2 ). The means and SDs of the change scores are presented in Table 4 .
Stepwise linear regression and SRB methods were then utilized to model change over time. Age, education, and sex were entered into all models as potential predictors of change. Baseline performance and change across previous trials when applicable was also entered into each model (i.e., baseline raw score entered into models for T 1 !T 2 change, T 2 !T 3 change, and T 1 !T 3 change; T 1 !T 2 change score also entered into models predicting T 2 !T 3 change and T 1 !T 3 change). Raw scores and change scores were used rather than standardized scores in these models, along with potential demographic predictors. Table 5 presents the resulting regression formulas for predicting the amount of expected change for each measure; note that previous performance consistently emerged as a significant predictor of subsequent performance. These change scores are average raw scores for the entire sample and do not consider patient characteristics, change score modifiers, or how these interact. These are the average change scores, and thus reflect the averaging of the effects of the predictors.
8
DEBORAH ATTIX ET AL. 
NORMATIVE NEUROPSYCHOLOGICAL TRAJECTORIES 9
Application. By performing simple computations, the clinician can use the SRB formulas presented in Part 2 to determine if a patient's observed change or practice effect deviates from expectation based on data from our normative sample. Rather than relying on accepted tradition or clinical judgment, these formulas provide an objective estimate of expected variability across multiple testing sessions while including the effects of variables that modify change. Consider the previous clinical example.
Our 56-year-old male obtained a score of 32 at baseline, but subsequently obtained scores of 23 and 25. In terms of reported events, the family described a change in cognition after he returned from vacation, but he himself was not aware of any precipitous event or cognitive decline. This prompted the second evaluation. The patient's second score of 23 represents a 9-point decrement from baseline, with the difference between the first and second score (32-23) falling at about 1 SD of the baseline sample mean (SD ¼ 8.7; see Table 2 ), which is an often applied threshold for clinically significant decline. By this standard, the observed change is a matter of concern but is not unequivocal evidence of clinically significant change. To assess whether this decrement from baseline is truly meaningful, we must consider the distribution of normal change scores and account for the potential impact demographic variables have on this distribution.
When considering average change across time in Table 4 , it appears that the patient's first decline differs considerably from the 3-point gain observed in this sample. However, the SD in change scores indicates considerable variability in change scores within this sample. To evaluate the significance of this change while considering the impact of performance and demographic variables, we apply the SRBs. We begin by estimating the patient's predicted change score using the Stroop regression equation for ÁT 1 !T 2 in Table 5 . We then subtract this score from the observed T 1 !T 2 difference and divide by the SEE. According to this outcome, the 9-point decline for this patient is indeed statistically rare, and likely to occur in only 1.3% of the normative sample. Given these data, which consider the patient's background as well as sources of error and bias, we no longer have a questionable change but rather a decline that clearly deviates from expectation.
The utility of the SRB method is also illustrated when considering this individual's change in performance by Time 3. His 2-point gain (23 to 25) actually falls above the average T2 to T3 change (M ¼ 1.06, SD ¼ 6.1; see Table 4 ), which at first glance might be considered an improved performance and consistent with expectation. When using the ÁT 2 !T 3 SRB equation, however, we see that this improvement actually deviates from his expected change by a z score of À.91 because his baseline performance, the prior T 1 to T 2 change, and demographic variables are considered. The use of these variables in the SRB model yields a more precise assessment of his expected trajectory of change. A similar point is made when considering the overall 7-point decrement from Time 1 to Time 3 (32-25).
When compared to group average change scores (M ¼ 4.25, SD ¼ 6.5; see Table 4 ) the patient's decline falls À1.73 standard deviations below the average practice effect. Use of the ÁT 1 !T 3 SRB equation, however, indicates that this overall decrement falls just short of one standard deviation below expected change when considering all relevant variables (z ¼ À.91). In each of these situations we see that the SRB equation was particularly useful when considering change over multiple time points and provided more accuracy than comparing performance to group average practice effects using change score means and standard deviations.
DISCUSSION
The practice of clinical neuropsychology is driven by the systematic application of measurement tools and principles, and typically boasts sound and strong normative resources (e.g., Lezak et al., 2004; Mitrushina et al., 2005; Strauss et al., 2006) . Yet the amount of data regarding normative change remains scarce given the frequency with which the clinician or researcher employs serial assessment for elucidating diagnosis, monitoring intervention outcomes, and tracking disease progression or recovery of function (Chelune, 2002; Chu et al., in press; McCrea et al., 2005) . The lack of published data on normative change places the clinician in a position of estimating practice effect changes for each measure used, while considering potential patient modifiers that may impact change as well, such as age, education, and sex. Regression to the mean, measurement error, and the effect of alternate forms must also be worked into the change gestalt (Lewis et al., 2006) . Longitudinal studies of normal samples offer us the opportunity to replace educated estimates with concrete data on normative change. Simpler concepts of ''back to baseline'' or ''one SD change'' based on the SD of the test rather than of change scores are replaced by data illustrating the sophisticated relationship between test scores and covariates over time. In addition to providing co-normed baseline data, this study presents formulas allowing for calculation of deviation from normal longitudinal change across three time points.
The co-standardization of baseline performance measures with appropriate demographic corrections on the same population has the potential to favorably facilitate interpretation and conceptualization and hence is presented for this sample. Co-norming reduces the need for clinically based interpretive adjustments made to correct for differences in norm group demographics, and methods of data standardization or data presentation.
In a similar fashion, an important advantage of using SRB models to construct change norms is that deviations from expected gains are expressed in a standardized z-score unit that is comparable across measures. Like co-standardized baseline data, co-normed change formulas yielding a consistent unit of deviation from change enhances interpretation of change, as modeling the norms using the same methodology within the same population essentially levels off the differential effects of practice, demographic modifiers, statistical artifacts, and inconsistent reliabilities across measures.
The increasing attention to the need for change data based on normals has produced SRB model norms across two or more time points (e.g., Duff et al., 2005 , Ivnik et al., 1999 , Sawrie et al., 1995 for select measures. This study augments these pioneering efforts by utilizing a relatively new approach wherein the normative data considers baseline and previous change in the models of subsequent change, yielding change estimates that are best conceptualized as reflecting change trajectories.
This study demonstrates important principles of neuropsychological change over time. First, while it is well accepted that patient demographics modify cognitive performance (Heaton et al., 2003) , review of age, education, and sex variables in these SRB models clearly demonstrate that these variables also often independently modify change in performance. Second, modifiers of baseline performance versus change performance are not always the same. Third, in terms of variables that most consistently modify change, the adage that ''. . . the best predictor of future behavior is past behavior'' fits well. Baseline and/or previous change always predicted subsequent change. While age and education often emerged as significant predictors, the impact of sex on change was minimal, and no demographic predicted change like previous performance did.
The effect of including baseline performance and previous change when applicable warrants careful attention. Baseline performance is considered in the estimates of change, which is critical, as evidenced by the predictive value of these prior performances in the change models. Low versus high performers will change differentially over time. However, inclusion of these scores in estimates of change also raises important interpretative considerations. Specifically, the degree of change from first to second assessment, through inclusion of these scores in the T 2 !T 3 and T 1 !T 3 models, will be considered in the predicted change scores for these latter models. Therefore, if the first change is notably discrepant from average, this discrepancy will be worked into the expectation for the change in the next interval. Inaccurate or aberrant baseline scores will also almost always influence the estimate of change at all time points. Nonetheless, inclusion of previous performance allows for consideration of known performance data that is clearly related to subsequent scores. As such, it is most useful to consider the serial normative formulas as truly modeling trajectories rather than simple change from point to point.
Given that change scores have their own unique distributions, application of these formulas, which model the effects of demographic and performance variables on change, will be most useful when the patient differs from the group average on these variables. Thus, at a minimum, use of SRB models is advocated over computations using group change means and standard deviations whenever the patient's demographics or performance variables deviate considerably from the norm group averages. SRB models also consider the sophisticated relationship among modifying variables and time, and should thus be utilized when estimating change across several time points. And finally, SRB models provide a level of precision that may be especially appropriate for research settings. In all of these cases, use of SRBs will enhance accuracy and precision.
Application of SRB methods to research programs can augment inferential statistics that show group differences that may be reliable but not necessarily meaningful by providing data on base rates of normal change (Chelune, 2002) . For instance, a recent study expanded on the inferential analysis of group differences in post-operative cognitive dysfunction between a high versus low depth of anesthesia 12 DEBORAH ATTIX ET AL.
study by incorporating SRB-based risk calculations. Using normal change base rates derived from a normal control sample, the investigators compared the percentage of patients in each anesthesia condition whose change scores exceeded those expected by chance in the normal sample (Farag et al., 2006) . It is important to note that because this study used a normal sample, the models are most useful for determining whether scores fall within the range of normal individuals. Rather than addressing abnormality, these models provide information about the rarity of change scores in a normal population. In contrast to those built on normal individuals, SRB models built on patient groups would provide valuable information about the course of illness, which can be important in gauging deviation from normal course or the effect of treatment. Indeed, models based on patient populations would be particularly useful for illnesses involving a dynamic course, such as the progressive deficits of Alzheimer's disease or the resolving deficits of traumatic brain injury. In future studies involving such populations, it will be important to model change trajectories. As noted, our application example highlights the effect of a markedly discrepant change score during the first interval on the subsequent expected trajectories and deviation scores. Clinically based SRB equations would be particularly useful in such cases, as the initial decline indicates that comparison to a relevant clinical population would be most valid for subsequent estimates. Also, it is important to emphasize that these data will be most applicable to samples similar to the archival one used here, and would not necessarily generalize to populations that differ considerably. Because ethnic minorities, women, and elders are either not included or are inadequately represented in this sample, application of these norms to these groups should be undertaken with considerable caution. These models may also not be applicable for patients seen at considerably shorter or longer test-retest intervals than those of the present sample. Finally, as with baseline norms, change norms require use of the same test versions as used in the standardization sample.
While performance norms can be found in multiple texts (e.g., Heaton et al., 2004; Lezak et al., 2004; Mitrushina et al., 2005; Strauss et al., 2006) , the paucity of serial normative data available to the clinician represents a pressing problem for our field. The challenge facing clinicians in the absence of such change data is considerable; estimating the differential impact of all the relevant variables accurately across measures and across time is a tremendous challenge. In addition, the effects of demographics, error, and bias on change scores for serial assessments are less understood than the effects of these variables at baseline. The present study was designed to contribute to the evolving norms and methodologies seeking to resolve these normative concerns. In addition to providing co-normed baseline data, these data augment the growing literature on calculating clinically significant, reliable change by providing averages and SRB models for multiple measures over multiple time points, and by modeling previous change into subsequent change formulas, yielding normative change trajectories.
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